How Mutations in a Virus Affect Cancer Development
Author Information
Author(s): Annette Balle Sørensen, Anders H Lund, Sandra Kunder, Leticia Quintanilla-Martinez, Jörg Schmidt, Bruce Wang, Matthias Wabl, Finn Skou Pedersen
Primary Institution: Department of Molecular Biology, University of Aarhus, Denmark
Hypothesis
Mutating alternative splice sites in the Akv murine leukemia virus will change its oncogenic properties.
Conclusion
Mutations in the alternative splice sites of the Akv murine leukemia virus alter the types of tumors it induces.
Supporting Evidence
- About 90% of infected mice developed tumors within 250 days.
- Histological examination showed that mutations changed tumor types and distributions.
- Single splice-site mutants produced a broader spectrum of tumor diagnoses.
Takeaway
Scientists changed a virus to see how it affects cancer in mice, and found that different changes led to different types of tumors.
Methodology
The study involved creating mutant viruses with altered splice sites and injecting them into newborn mice to observe tumor development.
Limitations
The study did not identify specific target genes or pathways associated with tumor diagnoses.
Participant Demographics
Newborn inbred NMRI mice were used in the experiments.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website